Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach

1. D. Sahu and A. Rana, Formulation development of Quetiapine Fumarate SR matrix tablets, Der Pharm. Sin. 1 (2010) 48-57.Search in Google Scholar

2. S. Cheer and A. Wagstaff, Quetiapine. A review of its use in the management of schizophrenia, CNS Drugs 18 (2004) 173-199; DOI: 10.2165/00023210-200418030-00004.10.2165/00023210-200418030-00004Search in Google Scholar

3. G. Garbacz, A. Kandzi, M. Koziolek, J. Mazgalski and W. Weitschies, Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions, AAPS PharmSciTech 15 (2014) 230-236; DOI: 10.1208/s12249-013-0050-2.10.1208/s12249-013-0050-2Search in Google Scholar

4. S. Chopra, G. V. Patil and S. K. Motwani, Release modulating hydrophilic matrix systems of losartan potassium: Optimization of formulation using statistical experimental design, Eur. J. Pharm. Biopharm. 66 (2007) 73-82; DOI: 10.1016/j.ejpb.2006.09.001.10.1016/j.ejpb.2006.09.001Search in Google Scholar

5. P. W. S. Heng, L. W. Chan, M. G. Easterbrook and X. Li, Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets, J. Control. Release 76 (2001) 39-49; DOI: 10.1016/S0168-3659(01)00410-2.10.1016/S0168-3659(01)00410-2Search in Google Scholar

6. S. Tiwari and A. R. Rajabi-Siahboomi, Modulation of drug release from hydrophilic matrices, Pharm. Tech. Eur. 20 (2008) 24-32.Search in Google Scholar

7. I. Tomuta and S. E. Leucuta, The influence of formulation factors on the kinetic release of metoprolol tartrate from Prolong release coated minitablets, Drug Dev. Ind. Pharm. 33 (2007) 1070-1077; DOI: 10.1080/03639040601180002.10.1080/03639040601180002Search in Google Scholar

8. R. Asija, S. Asija and M. Carpenter, Design of oral sustain release drug delivery of quetiapine fumarate, J. Drug Discov. Ther. 2 (2014) 7-11.Search in Google Scholar

9. S. Tiwari and A. Rajabi-Siahboomi, Applications of complementary polymers in HPMC hydrophilic extended release matrices, Drug Deliv. Technol. 9 (2009) 20-27.Search in Google Scholar

10. J. Djuriš, D. Medarević, M. Krstić, I. Vasiljević, I. Mašić and S. Ibrić, Design space approach in optimization of fluid bed granulation and tablets compression process, Sci. World J. (2012) 1-10; DOI: 10.1100/2012/185085.10.1100/2012/185085Search in Google Scholar

11. F. Rose, J. E. Wern, P. T. Ingvarsson, M. Van De, P. Andersen, F. Follmann and C. Foged, Engineering of a novel adjuvant based on lipid-polymer hybrid nanoparticles: A quality-by-design approach, J. Control. Release 28 (2015) 48-57; DOI: 10.1016/j.jconrel.2015.05.004.10.1016/j.jconrel.2015.05.004Search in Google Scholar

12. L. X. Yu, Pharmaceutical quality by design: Product and process development, understanding and control, Pharm. Res. 25 (2008) 781-791; DOI: 10.1007/s11095-007-9511-1.10.1007/s11095-007-9511-1Search in Google Scholar

13. A. L. Vonica-Gligor, I. Tomuţă and S. E. Leucuţa, Piecewise function parameters as responses of the design of experiment in the development of a pulsatile release chronopharmaceutical system, Acta Pol. Pharm. 66 (2016) 173-189; DOI: 10.1515/acph-2016-0025.10.1515/acph-2016-0025Search in Google Scholar

14. S. Dash, P. N. Murthy, L. Nath and P. Chowdhury, Kinetic modeling on drug release from controlled drug delivery systems, Acta Pol. Pharm. 67 (2010) 217-223; DOI: 10.1016/S0928-0987(01)00095-1.10.1016/S0928-0987(01)00095-1Search in Google Scholar

15. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 2009. ICH harmonised tripartite guideline: Pharmaceutical development Q8(R2); Retrieved from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdfSearch in Google Scholar

16. N. Charoo, A. Shamsher, A. Zidan and Z. Rahman, Quality by design approach for formulation development : A case study of dispersible tablets, Int. J. Pharm. 423 (2012) 167-178; DOI: 10.1016/j. ijpharm.2011.12.024.Search in Google Scholar

17. European Pharmacopeia 8.8. Online Edition 2016.Search in Google Scholar

18. S. Shahi, D. Magar, T. Ingale and H. Mene, QbD approach in formulation and evaluation of duloxetine Hcl bilayer buccal tablets, Lit. J. Pharm. Drug Deliv. Technol. 01 (2015) 29-36; DOI: 10.15272/ ljpddt.v1i1.8.Search in Google Scholar

19. MODDE 11.0. Software for Design of Experiments: User’s Guide and Tutorial, Umetrics Academy, Umea 2015.Search in Google Scholar

20. S. Iurian, I. Tomuta, C. Bogdan, L. Rus, T. Tokes, M. Achim, M. Moldovan and S. Leucuta, Defining the design space for freeze-dried orodispersible tablets with meloxicam, Drug Dev. Ind. Pharm. 9045 (2016); DOI: 10.1080/03639045.2016.1188108.10.1080/03639045.2016.1188108Search in Google Scholar

21. J. Wagner, Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules, J. Pharm. Sci. 58 (1969) 1253-1257; DOI: 10.1002/jps.2600581021. 10.1002/jps.2600581021Search in Google Scholar

22. I. Prasacu, C. Mircioiu, R. Sandulovici and F. Enache, Release of metoprolol from solid dosage forms. Choice and validation of theoretical model, Farmacia 57 (2009) 89-100.Search in Google Scholar

23. T. Higuchi, Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149.10.1002/jps.2600521210Search in Google Scholar

24. A. W. Hixson and J. H. Crowell, Dependence of reaction velocity upon surface and agitation, Ind. Eng. Chem. 23 (1931) 923-931.10.1021/ie50260a018Search in Google Scholar

25. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.10.1016/0378-5173(83)90064-9Search in Google Scholar

26. L. Eriksson, E. Johansson, N. Kettaneh-Wold, C. Wikstrom and S. Wold, Design of Experiments, Principles and Applications (3rd ed.), Umetrics Academy, Umea 2008.Search in Google Scholar

27. A. Porfire, I. Tomuta, D. Muntean, L. Luca, E. Licarete, M. C. Alupei, M. Achim, L. Vlase and M. Banciu, Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells, J. Liposome Res. (2014) 1-9; DOI: 10.3109/08982104.2014.987787.10.3109/08982104.2014.987787Search in Google Scholar

28. M. Levina and A. R. Rajabi-Siahboomi, The influence of excipients on drug release from hydroxypropyl methylcellulose matrices, J. Pharm. Sci. 93 (2004) 2746-2754; DOI: 10.1002/jps.20181.10.1002/jps.20181Search in Google Scholar

29. R. Rowe, P. Sheskey and M. Quinn, Handbook of Pharmaceutical Excipients (6th ed.), London: Pharmaceutical Press; DOI: 10.1016/S0168-3659(01)00243-7.10.1016/S0168-3659(01)00243-7Search in Google Scholar

30. C. Lui, Sustained Release with High and Low Viscosity HPMC, U.S. Pat. 5009895, 23 Apr 1991.Search in Google Scholar

31. J. Manjusha, G. Ganesh Vinayak and M. Satish Ramanlal, Sustained Release Formulation of Alprazolam, WO2007010369 A2, 25 Jan 2007.Search in Google Scholar

32. V. P. Shah, Y. Tsong, P. Sathe and J.-P. Liu, In vitro dissolution profile comparison - statistics and analysis of the similarity factor, f2 15 (1998) 889-896; DOI: 10.1023/A:1011976615750.10.1023/A:1011976615750Search in Google Scholar

33. P. Kulinowski, K. Woyna-Orlewicz, J. Obrał, G. M. Rappen, D. Haznar-Garbacz, W. P. Węglarz, R. Jachowicz, G. Wyszogrodzka, J. Klaja and P. P. Dorozyński, Multimodal approach to characterization of hydrophilic matrices manufactured by wet and dry granulation or direct compression methods, Int. J. Pharm. 499 (2016) 263-270; DOI: 10.1016/j.ijpharm.2015.12.067.10.1016/j.ijpharm.2015.12.06726752087Search in Google Scholar

34. P. Kulinowski, K. Woyna-Orlewicz, G. M. Rappen, D. Haznar-Garbacz, W. P. Weglarz and P. P. Dorozynski, An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance - Case study of multimodal characterization of quetiapine fumarate tablets, Int. J. Pharm. 484 (2015) 235-245; DOI: 10.1016/j.ijpharm.2015.02.040. 10.1016/j.ijpharm.2015.02.04025701626Search in Google Scholar